In a study including 214 surgically treated squamous cell carcinoma of the lung, the authors concluded that the incidence of PD-L1 over-expression was 19.6% and it was not related to patients' clinical outcomes [18]. This evidence concerns the gene CD274 and squamous cell lung carcinoma.